Literature DB >> 34084232

Central Macular Thickness in Diabetic Macular Edema.

H Gungel1, H Aral2, F Erdenen3, M Gokce4, S K Erdur5.   

Abstract

CONTEXT: Retinal microvascular dysfunction differs in macular edema lesions in the two eyes of the same patient with diabetic retinopathy.
OBJECTIVE: To evaluate the relationship between central macular thickness (CMT) and metabolic/systemic factors including anthropometric and laboratory findings, in patients with regressed diabetic retinopathy and a history of pars plana vitrectomy (PPV) combined with internal limiting membrane peeling in one eye. SUBJECTS AND METHODS: Forty-two eyes with PPV and the same patients' fellow 42 eyes (without PPV) included this study. Fasting blood samples of these 42 diabetics were collected to study adiponectin levels and other routine parameters.
RESULTS: The average hemoglobinA1c value was 7.3±1.3%. CMT of the vitrectomized eyes were significantly correlated with atherogenic index of plasma, total cholesterol, low density lipoprotein cholesterol and uric acid (UA). On the other hand, CMT of the nonvitrectomized fellow eyes significantly correlated with glucose levels and diabetes duration. Adiponectin, adiponectin/body mass index, adiponectin/fibrinogen were found significantly higher in the subgroup with CMT≥300μm in the vitrectomized eyes (P<0.05). UA levels were higher in the subgroup with CMT≥300μm in the fellow (nonvitrectomized) eyes (P<0.05).
CONCLUSIONS: Although there was no relationship between CMT and hemoglobinA1c values, CMT seemed to be affected by atherogenicity, prooxidant chemical alterations in the course of inflammation, so determination of adiponectin and UA levels may be suggested before surgery to predict the atherosclerotic damage and the postoperative CMT value. Vitrectomy performed at the proper time may be helpful in metabolic remodeling process of the retinal tissue along with life style changes, well control of diabetes, and intraocular treatments. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  Adiponectin; central macular thickness; diabetic retinopathy; metabolism; uric acid

Year:  2020        PMID: 34084232      PMCID: PMC8126384          DOI: 10.4183/aeb.2020.417

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  40 in total

Review 1.  Regulation of uric acid metabolism and excretion.

Authors:  Jessica Maiuolo; Francesca Oppedisano; Santo Gratteri; Carolina Muscoli; Vincenzo Mollace
Journal:  Int J Cardiol       Date:  2015-08-14       Impact factor: 4.164

2.  Association of serum inflammatory markers and diabetic retinopathy: a review of literature.

Authors:  N S Gouliopoulos; C Kalogeropoulos; A Lavaris; A Rouvas; I Asproudis; A Garmpi; C Damaskos; N Garmpis; A Kostakis; M M Moschos
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-11       Impact factor: 3.507

3.  Apoptosis in diabetic fibrovascular membranes after panretinal photocoagulation.

Authors:  Anh T Tran; Deisy V Bula; Kyle D Kovacs; Judy Savageau; Jorge G Arroyo
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010-06-30

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 5.  Dyslipidemia and Diabetic Macular Edema: A Systematic Review and Meta-Analysis.

Authors:  Radha Das; Rebecca Kerr; Usha Chakravarthy; Ruth E Hogg
Journal:  Ophthalmology       Date:  2015-07-03       Impact factor: 12.079

6.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

7.  Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.

Authors:  Masahiko Shimura; Kanako Yasuda; Toru Nakazawa; Tetsuya Kano; Satsuki Ohta; Makoto Tamai
Journal:  Ophthalmology       Date:  2003-12       Impact factor: 12.079

8.  Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Nutr Metab (Lond)       Date:  2004-10-19       Impact factor: 4.169

9.  Effects of fenofibrate on adiponectin expression in retinas of streptozotocin-induced diabetic rats.

Authors:  Ying-Jung Hsu; Lu-Chun Wang; Wei-Shiung Yang; Chung-May Yang; Chang-Hao Yang
Journal:  J Diabetes Res       Date:  2014-12-01       Impact factor: 4.011

10.  Association of Serum Uric Acid Concentration with Diabetic Retinopathy and Albuminuria in Taiwanese Patients with Type 2 Diabetes Mellitus.

Authors:  Ching-Chao Liang; Pi-Chen Lin; Mei-Yueh Lee; Szu-Chia Chen; Shyi-Jang Shin; Pi-Jung Hsiao; Kun-Der Lin; Wei-Hao Hsu
Journal:  Int J Mol Sci       Date:  2016-08-02       Impact factor: 5.923

View more
  2 in total

1.  Interleaved Optical Coherence Tomography: Clinical and Laboratory Biomarkers in Patients with Diabetic Macular Edema.

Authors:  Corina-Iuliana Suciu; Vlad-Ioan Suciu; Ancuţa Cuţaş; Simona Delia Nicoară
Journal:  J Pers Med       Date:  2022-05-09

2.  The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy.

Authors:  Chunyan Lei; Yun Zhang; Meixia Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.